The primary mission of Nerve Access is to develop and commercialize pharmaceuticals and related medical products that can enhance neural regeneration and functional recovery after neurological disorders.
For hundreds of years, neuroscientists had indicated that regenerating the cells and tissues of the CNS after neurological injury was not possible.However, recent research has indicated that replacing damaged CNS cells and tissues can be achieved.Accordingly, our team has been looking for therapeutics and related products that can enhance the regenerative capacity of the CNS.These products include cellular and molecular components, as well as tissue conduits, and can be used to improve functional recovery after neurodegenerative diseases such as Alzheimer?s disease (AD), stroke, Parkinson?s disease, multiple sclerosis, spinal cord injury, traumatic brain injury, etc.